- Home
- AMBC vs AMLX Comparison
AMBC vs AMLX Comparison
Compare AMBC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- AMLX
- Stock Information
- Founded
- AMBC 1971
- AMLX 2014
- Country
- AMBC United States
- AMLX United States
- Employees
- AMBC N/A
- AMLX N/A
- Industry
- AMBC Property-Casualty Insurers
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- AMLX Health Care
- Exchange
- AMBC Nasdaq
- AMLX Nasdaq
- Market Cap
- AMBC 411.3M
- AMLX 459.1M
- IPO Year
- AMBC 1991
- AMLX 2022
- Fundamental
- Price
- AMBC $6.76
- AMLX $5.05
- Analyst Decision
- AMBC Strong Buy
- AMLX Buy
- Analyst Count
- AMBC 1
- AMLX 6
- Target Price
- AMBC $15.00
- AMLX $10.17
- AVG Volume (30 Days)
- AMBC 1.1M
- AMLX 911.0K
- Earning Date
- AMBC 08-04-2025
- AMLX 08-07-2025
- Dividend Yield
- AMBC N/A
- AMLX N/A
- EPS Growth
- AMBC N/A
- AMLX N/A
- EPS
- AMBC N/A
- AMLX N/A
- Revenue
- AMBC $253,912,000.00
- AMLX N/A
- Revenue This Year
- AMBC N/A
- AMLX N/A
- Revenue Next Year
- AMBC $17.41
- AMLX N/A
- P/E Ratio
- AMBC N/A
- AMLX N/A
- Revenue Growth
- AMBC 125.08
- AMLX N/A
- 52 Week Low
- AMBC $5.99
- AMLX $1.62
- 52 Week High
- AMBC $13.64
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- AMBC 38.39
- AMLX 48.04
- Support Level
- AMBC $6.65
- AMLX $5.24
- Resistance Level
- AMBC $7.18
- AMLX $5.66
- Average True Range (ATR)
- AMBC 0.35
- AMLX 0.34
- MACD
- AMBC -0.05
- AMLX -0.05
- Stochastic Oscillator
- AMBC 17.88
- AMLX 21.97
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.